Companies / Lyterian Therapeutics
Lyterian Therapeutics
Company
Lyterian Therapeutics develops medicines for patients by co-opting protein homeostatic mechanisms to regulate genetically-validated targets.
Lyterian Therapeutics has 1 investor on file, among them The Column Group. Its site was last checked 12 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from The Column Group
37 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (95%), Fintech (3%), E-commerce & Marketplaces (3%).
See The Column Group's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Lyterian Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when The Column Group adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/lyterian.com/investors
# also
GET /v1/companies/lyterian.com
GET /v1/companies/lyterian.com/news